ROCHELLE DYER: Open Payments
NPI 1487619896 · MOUNT AIRY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,196 in 72 payments from 16 companies in 2025. Trend: 2023 $1,083 · 2024 $1,149 · 2025 $1,196
Food & beverage: $1,196
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $395 |
| Novo Nordisk Inc | 7 | $170 |
| PFIZER INC. | 10 | $148 |
| Baxter Healthcare | 3 | $67 |
| Exact Sciences Corporation | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Lilly USA, LLC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: VRAYLAR, NURTEC ODT, Rybelsus, Wegovy, BREZTRI, MOUNJARO, UBRELVY, QULIPTA.
Industry payments across MD — which companies pay providers there.
